Abstract
ObjectiveTumour necrosis factor signalling via the receptor-interacting protein kinase 1 (RIPK1) pathway regulates colonic inflammation suggesting that RIPK1 inhibition may be a potential therapeutic target in ulcerative colitis (UC). This...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have